United States Regenerative Medicine Market By Type (Cell-based immunotherapy & Cell therapy products, Gene therapy products, Tissue-engineered products, Others), By Material (Biologically Derived Material, Synthetic Material, Pharmaceuticals, Genetically

United States Regenerative Medicine Market By Type (Cell-based immunotherapy & Cell therapy products, Gene therapy products, Tissue-engineered products, Others), By Material (Biologically Derived Material, Synthetic Material, Pharmaceuticals, Genetically Engineered Material, Others), By Application (Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, Others), By Region, Forecast & Opportunities, 2025

United States regenerative medicine market is expected to witness robust CAGR until 2025. The United States regenerative medicine market is driven by the growing popularity of stem cell-based therapies. Additionally, the use of regenerative medicines for treating chronic diseases, acute insults and maladies is further propelling the market in the country.

The United States regenerative medicine market is segmented based on type, material, application, company and region. Based on type, the market can be categorized into cell-based immunotherapy & cell therapy products, gene therapy products, tissue-engineered products and others. The cell-based immunotherapy & cell therapy products segment is expected to dominate the market during forecast years on account of the growing demand for cell-based immunotherapies and establishment of cures act by FDA to streamline the regenerative medicine market. The segment has the most promising future on account of its capability to restore the lost function of tissues and organs. Based on application, the market can be fragmented into musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, dermatology and others. The dermatology application segment is expected to hold a significant market share during the forecast years. This can be attributed to the presence of easy grafting techniques for dermatological wounds and diseases.

Major players operating in the United States regenerative medicine market include Kite Pharma (Gilead Sciences), Novartis, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, SanBio, Inc., Hitachi Chemical Advanced Therapeutics Solutions, LLC, Integra LifeSciences, Osiris Therapeutics, Inc., Pfizer Inc, Baxter International Inc., GlaxoSmithKline plc., Bayer Corporation and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments. For instance, in 2017, Integra LifeSciences launched a new product, “Thin”- Integra dermal regeneration template single layer for dermal repair defects reconstruction in a single step procedure. Also, in 2018, SanBio Group signed an agreement with Hitachi Chemical Advanced Therapeutics Solutions, LLC for the development and contract manufacturing of regenerative medicines.

Years considered for this report:

Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025

Objective of the Study:

To analyze and forecast the market size of United States regenerative medicine market.
To classify and forecast United States regenerative medicine market based on type, material, application, company and regional distribution.
To identify drivers and challenges for United States regenerative medicine market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States regenerative medicine market.
To identify and analyze the profile of leading players operating in United States regenerative medicine market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed new product offerings, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of United States regenerative medicine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

Regenerative medicine manufacturers, suppliers and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to regenerative medicine
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, United States regenerative medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Market, By Type:
Cell-based immunotherapy & Cell therapy products
Gene therapy products
Tissue-engineered products
Others
Market, By Material:
Biologically Derived Material
Synthetic Material
Pharmaceuticals
Genetically Engineered Material
Others

Market, By Application:


Musculoskeletal Disorders
Wound Care
Oncology
Ocular Disorders
Diabetes
Dermatology
Others

Market, By Region:


North-East
Mid-West
West
South

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States regenerative medicine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. United States Regenerative Medicine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Cell-based immunotherapy & Cell therapy products, Gene therapy products, Tissue-engineered products, Others)
5.2.2. By Material (Biologically Derived Material, Synthetic Material, Pharmaceuticals, Genetically Engineered Material, Others)
5.2.3. By Application (Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, Dermatology, Others)
5.2.4. By Region
5.2.5. By Company (2019)
5.3. Product Market Map
6. North-East United States Regenerative Medicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Material
6.2.3. By Application
7. Mid-West United States Regenerative Medicine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Material
7.2.3. By Application
8. West United States Regenerative Medicine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Material
8.2.3. By Application
9. South United States Regenerative Medicine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Material
9.2.3. By Application
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
12. Policy & Regulatory Landscape
13. United States Economic Profile
14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Company Details
14.2.1.1. Kite Pharma (Gilead Sciences)
14.2.1.2. Novartis
14.2.1.3. Merck & Co., Inc.
14.2.1.4. Vertex Pharmaceuticals Incorporated
14.2.1.5. SanBio, Inc.
14.2.1.6. Hitachi Chemical Advanced Therapeutics Solutions, LLC
14.2.1.7. Integra LifeSciences
14.2.1.8. Osiris Therapeutics, Inc.
14.2.1.9. Pfizer Inc
14.2.1.10. Baxter International Inc.
14.2.1.11. GlaxoSmithKline plc.
14.2.1.12. Bayer Corporation
15. Strategic Recommendations
16. About Us & Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook